article 3 months old

Australian Broker Call *Extra* Edition – Mar 07, 2024

Daily Market Reports | Mar 07 2024

This story features 29METALS LIMITED, and other companies. For more info SHARE ANALYSIS: 29M

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.

In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.

One key difference is the *Extra* Edition will not be updated daily, but merely "regularly" depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.

Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena's team of journalists.

Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.

The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.

The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.

COMPANIES DISCUSSED IN THIS ISSUE

Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)

29M   ABB   ACE   ADH (2)   ASB   ASG   AVA   AX1 (2)   BXB (2)   CCR   CMM   CSR   CYG   EDV   ESK   FMG   GMG   GNX   GOR   GTN   IGO   IPH   JIN   LAU   LFG   LOV   MHJ   MYX   NAN   NHF   NXD   OCL   PBH   PLS   PNV   PPE (2)   PPS   PSQ   PXA (2)   QAN   RDY   REG   SFR (2)   SMR   STX   SUN   TAH   TLX   TPG   TYR   UNI   VIT   WDS   WPR  

29M    29METALS LIMITED

Copper – Overnight Price: $0.36

Jarden rates ((29M)) as Overweight (2) –

29Metals 2023 results are described by Jarden as "confronting". The underlying EBITDA loss of -$21m was slightly ahead of forecasts. No changes have been made to recent guidance. The broker reduces forecast for 2024 EBITDA by -15%, given an expected slower recovery at Capricorn Copper.

The company needs to secure approval to deposit the tailings in the E-pit by April or the asset will move into care & maintenance. Jarden pushes out the recovery to full production to late 2024 and is confident that the operating profile will be uninterrupted.

The broker points out the longer that copper and zinc prices are at current levels the more likely additional funding will be required for the company to remain solvent. Overweight. Target edges down to $0.38 from $0.39.

This report was published on February 23, 2024.

Target price is $0.38 Current Price is $0.36 Difference: $0.015
If 29M meets the Jarden target it will return approximately 4% (excluding dividends, fees and charges).
Current consensus price target is $0.43, suggesting upside of 17.8%(ex-dividends)
The company's fiscal year ends in December.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 4.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 7.93.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -13.7, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY25:

Jarden forecasts a full year FY25 EPS of 14.80 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 2.47.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 0.8, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 45.6.

Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

ABB    AUSSIE BROADBAND LIMITED

Telecommunication – Overnight Price: $4.41

Wilsons rates ((ABB)) as Overweight (1) –

Aussie Broadband has submitted a non-binding indicative proposal to acquire Superloop ((SLC)) by way of a scheme of arrangement. Wilsons notes, if successful, the acquisition would result in the combined business having a market share of 11.8% of the NBN and be the fourth biggest wholesale provider.

The broker considers the price, SLC shareholders will receive 0.21 ABB shares for each share which, based on the last ABB closing price implies a total value to Superloop shareholders of $0.95.

Wilsons considers the proposal somewhat opportunistic and there are few players that could probably compete with the offer. No ACCC issues are envisaged. Overweight. Target is $5.80.

This report was published on February 27, 2024.

Target price is $5.80 Current Price is $4.41 Difference: $1.39
If ABB meets the Wilsons target it will return approximately 32% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Wilsons forecasts a full year FY24 dividend of 0.00 cents and EPS of 16.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 27.56.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of 27.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.04.

Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

ACE    ACUSENSUS LIMITED

Transportation & Logistics – Overnight Price: $0.68

Wilsons rates ((ACE)) as No Rating (-1) –

Acusensus posted a strong first half due to its success domestically, Wilsons observes. With FY24 being a year of investment, the broker assesses FY25 should be when some of the returns are realised.

Revenue grew 25% and gross profit 32%. Key wins include a new 5-year-plus contract with South Australia for multiple fixed mobile phone detection installations and expansion of the number of trailers for mobile phone and seatbelt enforcement in Queensland.

In international business the company has moved from one-off pilots to medium-term engagements in the UK and opened up the market in the US.

There is no rating on the stock.

This report was published on February 27, 2024.

Current Price is $0.68. Target price not assessed.

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

ADH    ADAIRS LIMITED

Furniture & Renovation – Overnight Price: $2.31

Jarden rates ((ADH)) as Neutral (3) –

First half results from Adairs beat estimates although Jarden observes it was a lower quality result, driven by depreciation and amortisation.

The broker acknowledges management's "good job" navigating a tough cost and sales environment but retains a Neutral rating as the stock is trading at a FY24 PE of around 11x and forecasts reflect significant execution risk.

The broker envisages better relative value elsewhere, although would reconsider its view if there was sustainable improvement in comparables. Target is raised to $ 2.09 from $1.45.

This report was published on February 27, 2024.

Target price is $2.09 Current Price is $2.31 Difference: minus $0.22 (current price is over target).
If ADH meets the Jarden target it will return approximately minus 10% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $2.20, suggesting downside of -4.8%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 EPS of 19.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.91.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 19.1, implying annual growth of -13.1%.
Current consensus DPS estimate is 7.8, implying a prospective dividend yield of 3.4%.
Current consensus EPS estimate suggests the PER is 12.1.

Forecast for FY25:

Jarden forecasts a full year FY25 EPS of 24.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.63.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 23.3, implying annual growth of 22.0%.
Current consensus DPS estimate is 15.0, implying a prospective dividend yield of 6.5%.
Current consensus EPS estimate suggests the PER is 9.9.

Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Wilsons rates ((ADH)) as Upgrade to Market Weight from Underweight (3) –

First half results from Adairs were mixed with sales in line and net profit ahead amid a strong rebound in gross margins and cost control. Wilsons notes gross margins recovered despite value-seeking consumers, while the top line was held back by limited stock.

The issues with the margin for Mocka appear resolved although the broker notes the core customer remains value-oriented and volatile.

Execution on costs and the ability to show pricing power results in Wilsons upgrading to Market Weight from Underweight. Target is raised to $2.00 from $1.10.

This report was published on February 27, 2024.

Target price is $2.00 Current Price is $2.31 Difference: minus $0.31 (current price is over target).
If ADH meets the Wilsons target it will return approximately minus 13% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $2.20, suggesting downside of -4.8%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Wilsons forecasts a full year FY24 dividend of 7.50 cents and EPS of 19.10 cents.
At the last closing share price the estimated dividend yield is 3.25%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.09.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 19.1, implying annual growth of -13.1%.
Current consensus DPS estimate is 7.8, implying a prospective dividend yield of 3.4%.
Current consensus EPS estimate suggests the PER is 12.1.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 5.00 cents and EPS of 19.20 cents.
At the last closing share price the estimated dividend yield is 2.16%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.03.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 23.3, implying annual growth of 22.0%.
Current consensus DPS estimate is 15.0, implying a prospective dividend yield of 6.5%.
Current consensus EPS estimate suggests the PER is 9.9.

Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

ASB    AUSTAL LIMITED

Commercial Services & Supplies – Overnight Price: $2.10

Petra Capital rates ((ASB)) as Buy (1) –

Austal's 1H results were in line with Petra Capital's forecasts. Despite a -7.4% decline in revenue, $12m of net profit compares favourably to the net loss of -$7.3m in the previous corresponding period, as the earnings (EBIT) margin improved.

The 4.4% margin, while still below management's targeted range of 8-10%, reflected a better mix of higher-margin workflow and better support margins as newer programs ramp-up, explains the analyst.

Management reiterated FY24 sales guidance of between $1.71- 1.74bn and earnings of $51-70m. 

Petra Capital's earnings forecasts are unchanged, and the $3.08 target and Buy rating are maintained.

This report was published on February 27, 2024.

Target price is $3.08 Current Price is $2.10 Difference: $0.98
If ASB meets the Petra Capital target it will return approximately 47% (excluding dividends, fees and charges).
Current consensus price target is $2.68, suggesting upside of 27.8%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Petra Capital forecasts a full year FY24 dividend of 7.00 cents and EPS of 12.10 cents.
At the last closing share price the estimated dividend yield is 3.33%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.36.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 4.7, implying annual growth of N/A.
Current consensus DPS estimate is 4.0, implying a prospective dividend yield of 1.9%.
Current consensus EPS estimate suggests the PER is 44.7.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 7.50 cents and EPS of 11.10 cents.
At the last closing share price the estimated dividend yield is 3.57%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.92.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 12.3, implying annual growth of 161.7%.
Current consensus DPS estimate is 3.3, implying a prospective dividend yield of 1.6%.
Current consensus EPS estimate suggests the PER is 17.1.

Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

ASG    AUTOSPORTS GROUP LIMITED

Automobiles & Components – Overnight Price: $2.34

Jarden rates ((ASG)) as Overweight (2) –

Pre-tax profit from Autosports Group slightly beat Jarden's estimates. The broker has a positive view on the stock, noting its ability to take share of the luxury electric vehicle market from Tesla, with traditional OEMs historically under-represented in this category and BMW, Mercedes and Audi now releasing luxury EV models.

EPS forecasts are revised down -1.6% for FY24 and -3.6% for FY25, driven by revenue upgrades and gross profit margin contraction as well as increased interest costs. Overweight. Target is reduced to $3.25 from $3.35.

This report was published on February 23, 2024.

Target price is $3.25 Current Price is $2.34 Difference: $0.91
If ASG meets the Jarden target it will return approximately 39% (excluding dividends, fees and charges).
Current consensus price target is $3.12, suggesting upside of 33.2%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 20.30 cents and EPS of 35.20 cents.
At the last closing share price the estimated dividend yield is 8.68%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 6.65.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 35.5, implying annual growth of 9.1%.
Current consensus DPS estimate is 19.9, implying a prospective dividend yield of 8.5%.
Current consensus EPS estimate suggests the PER is 6.6.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 19.90 cents and EPS of 34.70 cents.
At the last closing share price the estimated dividend yield is 8.50%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 6.74.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 30.7, implying annual growth of -13.5%.
Current consensus DPS estimate is 18.5, implying a prospective dividend yield of 7.9%.
Current consensus EPS estimate suggests the PER is 7.6.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

AVA    AVA RISK GROUP LIMITED

Hardware & Equipment – Overnight Price: $0.16

Petra Capital rates ((AVA)) as Buy (1) –

Thanks to quarterly reporting, sales orders and revenue numbers for Ava Risk were known in advance of 1H results.

Employee expenses increased materially, notes Petra Capital, as management raised capability to chase larger wins, which was evident from the record 2Q sales order intake.

While a 1H profit dip was disappointing, the broker believes expenses incurred during the period were necessary to attain longer-term management targets.

After a modest 1H for revenue growth, according to the analyst, management is expecting a substantially better 2H as contracts secured in 1H are executed.

The target falls to 36c from 42c. Buy.

This report was published on February 27, 2024.

Target price is $0.36 Current Price is $0.16 Difference: $0.2
If AVA meets the Petra Capital target it will return approximately 125% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Petra Capital forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 0.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 26.67.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of 1.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.67.

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

AX1    ACCENT GROUP LIMITED

Apparel & Footwear – Overnight Price: $1.92

Jarden rates ((AX1)) as Neutral (3) –

Jarden considers Accent Group has done a good job navigating in a tough environment, having not experienced significant downgrades compared with some retailers.

First half net profit may have missed forecasts but the trading update reveals momentum, with costs increasing less than during the first half.

Guidance is for 20 stores to be opened in the second half and, while this may be slower than the market had anticipated, the broker counters it could present upside if it accelerates and the company is able to execute on the opportunity.

Neutral. Target is raised to $2.05 from $1.87.

This report was published on February 24, 2024.

Target price is $2.05 Current Price is $1.92 Difference: $0.135
If AX1 meets the Jarden target it will return approximately 7% (excluding dividends, fees and charges).
Current consensus price target is $2.25, suggesting upside of 17.3%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 11.10 cents and EPS of 10.10 cents.
At the last closing share price the estimated dividend yield is 5.80%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.96.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 11.4, implying annual growth of -29.5%.
Current consensus DPS estimate is 10.9, implying a prospective dividend yield of 5.7%.
Current consensus EPS estimate suggests the PER is 16.8.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 12.00 cents and EPS of 12.00 cents.
At the last closing share price the estimated dividend yield is 6.27%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.96.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 14.6, implying annual growth of 28.1%.
Current consensus DPS estimate is 13.2, implying a prospective dividend yield of 6.9%.
Current consensus EPS estimate suggests the PER is 13.1.

Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Petra Capital rates ((AX1)) as Hold (3) –

Following in-line 1H results for Accent Group, Petra Capital highlights an ongoing healthy gross margin percentage. It's felt this points to a right-sized inventory position (i.e. less markdowns/promotions), some freight tailwinds and an increasing vertical sales mix.

More negatively, cost-of-doing business (CODB) -wage and rent inflation- was slightly up on the broker's forecast for the half and remains a key headwind.

The $2.10 target and Hold rating are maintained.

This report was published on February 27, 2024.

Target price is $2.10 Current Price is $1.92 Difference: $0.185
If AX1 meets the Petra Capital target it will return approximately 10% (excluding dividends, fees and charges).
Current consensus price target is $2.25, suggesting upside of 17.3%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Petra Capital forecasts a full year FY24 dividend of 13.00 cents and EPS of 12.00 cents.
At the last closing share price the estimated dividend yield is 6.79%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.96.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 11.4, implying annual growth of -29.5%.
Current consensus DPS estimate is 10.9, implying a prospective dividend yield of 5.7%.
Current consensus EPS estimate suggests the PER is 16.8.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 12.70 cents and EPS of 15.10 cents.
At the last closing share price the estimated dividend yield is 6.63%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.68.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 14.6, implying annual growth of 28.1%.
Current consensus DPS estimate is 13.2, implying a prospective dividend yield of 6.9%.
Current consensus EPS estimate suggests the PER is 13.1.

Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

BXB    BRAMBLES LIMITED

Transportation & Logistics – Overnight Price: $15.31

Goldman Sachs rates ((BXB)) as Sell (5) –

In the wake of the Brambles first half results, where the underlying operating performance was better than forecast, Goldman Sachs updates FY24-26 earnings estimates.

FY24 net profit estimates are reduced by -1% while FY26 are raised by 2%. Sell rating maintained. Target is reduced to $14.45.

This report was published on February 23, 2024.

Target price is $14.45 Current Price is $15.31 Difference: minus $0.86 (current price is over target).
If BXB meets the Goldman Sachs target it will return approximately minus 6% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $15.44, suggesting upside of 0.9%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Goldman Sachs forecasts a full year FY24 dividend of 41.02 cents and EPS of 80.51 cents.
At the last closing share price the estimated dividend yield is 2.68%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.02.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 89.8, implying annual growth of N/A.
Current consensus DPS estimate is 48.0, implying a prospective dividend yield of 3.1%.
Current consensus EPS estimate suggests the PER is 17.0.

Forecast for FY25:

Goldman Sachs forecasts a full year FY25 dividend of 44.05 cents and EPS of 86.59 cents.
At the last closing share price the estimated dividend yield is 2.88%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.68.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 100.3, implying annual growth of 11.7%.
Current consensus DPS estimate is 54.3, implying a prospective dividend yield of 3.5%.
Current consensus EPS estimate suggests the PER is 15.3.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Jarden rates ((BXB)) as Overweight (2) –

First half earnings from Brambles were in line and Jarden highlights the guidance upgrade for underlying profit growth of 13-15% from 9-12%. This improves the free cash flow outlook pre-dividends.

The broker notes much of the conjecture regarding the outlook has centred on pricing momentum which it suspects misses the point that prices are falling at a slower rate relative to costs.

The top end of guidance appears achievable should current conditions prevail and the broker retains an Overweight rating. Target is raised to $15.70 from $15.35.

This report was published on February 23, 2024.

Target price is $15.70 Current Price is $15.31 Difference: $0.39
If BXB meets the Jarden target it will return approximately 3% (excluding dividends, fees and charges).
Current consensus price target is $15.44, suggesting upside of 0.9%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 72.76 cents and EPS of 81.73 cents.
At the last closing share price the estimated dividend yield is 4.75%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.73.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 89.8, implying annual growth of N/A.
Current consensus DPS estimate is 48.0, implying a prospective dividend yield of 3.1%.
Current consensus EPS estimate suggests the PER is 17.0.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 80.81 cents and EPS of 90.23 cents.
At the last closing share price the estimated dividend yield is 5.28%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.97.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 100.3, implying annual growth of 11.7%.
Current consensus DPS estimate is 54.3, implying a prospective dividend yield of 3.5%.
Current consensus EPS estimate suggests the PER is 15.3.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CCR    CREDIT CLEAR LIMITED

Diversified Financials – Overnight Price: $0.27

Petra Capital rates ((CCR)) as Buy (1) –

Credit Clear's 1H results were largely pre-announced during 2Q results.

Petra Capital's forecasts were already ahead of prior management guidance, and now the broker makes further upgrades as leverage is being realised. Gross profit margins expanded to 54% from 51% due to good cost control, explains the analyst.

The company signed 225 new clients during the quarter.

Management issued new revenue guidance of $40m- $42m, and forecast earnings (EBITDA-U) will exceed $3m, up from prior guidance for between $1-2m.

Buy rating retained. The target rises to 43c from 40c.

This report was published on February 27, 2024.

Target price is $0.43 Current Price is $0.27 Difference: $0.16
If CCR meets the Petra Capital target it will return approximately 59% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Petra Capital forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 1.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 19.29.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 0.70 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 38.57.

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CMM    CAPRICORN METALS LIMITED

Gold & Silver – Overnight Price: $5.17

Canaccord Genuity rates ((CMM)) as Buy (1) –

First half earnings (EBITDA) for Capricorn Metals were in line with Canaccord Genuity's forecast though were an 8% beat compared to the consensus estimate. Profit matched forecasts made by both the broker and consensus.

The broker points out Capricorn remains unhedged over FY24 and is exposed to current spot prices of around $3,104/oz. Hedge obligations resume in FY25, with 107koz hedged at an average price of $2,327/oz.

Management left FY24 guidance unchanged.

The Buy rating and $5.75 target are maintained. Petra Capital assumes nameplate production at Mt Gibson in 2026 (September quarter)
with meaningful plant construction activities beginning in mid-FY25.

This report was published on February 28, 2024.

Target price is $5.75 Current Price is $5.17 Difference: $0.58
If CMM meets the Canaccord Genuity target it will return approximately 11% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Canaccord Genuity forecasts a full year FY24 dividend of 0.00 cents and EPS of 28.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.46.

Forecast for FY25:

Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of 29.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.83.

Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CSR    CSR LIMITED

Building Products & Services – Overnight Price: $8.83

Jarden rates ((CSR)) as Neutral (3) –

CSR has agreed to the takeover by Saint Gobain with the proposed $9 per share bid unanimously recommended by the board. Jarden does not expect any issues regarding approvals.

The transaction is for the whole of the company and includes the aluminium interests and asbestos liabilities.

Saint Gobain has initially committed to the re-powering process at Tomago, with the electricity contract due 2028, and thereafter will explore its options. The broker increases the target to $9.00 from $6.60 and retains a Neutral rating.

This report was published on February 27, 2024.

Target price is $9.00 Current Price is $8.83 Difference: $0.17
If CSR meets the Jarden target it will return approximately 2% (excluding dividends, fees and charges).
Current consensus price target is $7.37, suggesting downside of -16.5%(ex-dividends)
The company's fiscal year ends in March.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 38.00 cents and EPS of 54.70 cents.
At the last closing share price the estimated dividend yield is 4.30%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.14.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 45.2, implying annual growth of -0.7%.
Current consensus DPS estimate is 33.3, implying a prospective dividend yield of 3.8%.
Current consensus EPS estimate suggests the PER is 19.5.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 32.60 cents and EPS of 46.60 cents.
At the last closing share price the estimated dividend yield is 3.69%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.95.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 38.6, implying annual growth of -14.6%.
Current consensus DPS estimate is 30.2, implying a prospective dividend yield of 3.4%.
Current consensus EPS estimate suggests the PER is 22.9.

Market Sentiment: -0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CYG    COVENTRY GROUP LIMITED

Hardware & Equipment – Overnight Price: $1.40

Petra Capital rates ((CYG)) as Buy (1) –

Coventry Group posted an 18.1% increase in underlying earnings (EBITDA) for the 1H, largely due to the ongoing strength of the Fluid Systems business, where earnings increased by 24%.

While Nubco (hardware and industrial products) and Konnect and Artia New Zealand (KANZ) are currently experiencing weak trading conditions, the broker expects an improvement later in 2024.

Along with higher margins expected in Konnect and Artia Australia (KAA), the analyst sees a strong Trade Distribution performance in FY25, supplemented by the benefits from an ERP upgrade, scheduled for late-2024 delivery.

Management is aiming for long-term earnings margins of 10%, well ahead of Petra Capital's 7.5% estimate in FY26.

The Buy rating and $2.29 target are maintained.

This report was published on February 27, 2024.

Target price is $2.29 Current Price is $1.40 Difference: $0.89
If CYG meets the Petra Capital target it will return approximately 64% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Petra Capital forecasts a full year FY24 dividend of 4.00 cents and EPS of 12.00 cents.
At the last closing share price the estimated dividend yield is 2.86%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.67.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 7.50 cents and EPS of 17.80 cents.
At the last closing share price the estimated dividend yield is 5.36%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.87.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

EDV    ENDEAVOUR GROUP LIMITED

Food, Beverages & Tobacco – Overnight Price: $5.24

Jarden rates ((EDV)) as Overweight (2) –

Jarden found the first half result from Endeavour Group "clean" and slightly ahead of expectations. While margins were well controlled, the broker points out the trading update was weaker with retail sales up just 0.3% for the first seven weeks of the second half, implying a decline in January.

The main news the broker highlights was the $1bn-plus revised value of the freehold property with the company looking to crystallise this and it would be both accretive to returns on invested capital and earnings per share and a catalyst for a re-rating.

The risk/reward is looking increasingly attractive and Jarden retains an Overweight rating and $6.40 target.

This report was published on February 26, 2024.

Target price is $6.40 Current Price is $5.24 Difference: $1.16
If EDV meets the Jarden target it will return approximately 22% (excluding dividends, fees and charges).
Current consensus price target is $5.74, suggesting upside of 9.5%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 22.30 cents and EPS of 29.90 cents.
At the last closing share price the estimated dividend yield is 4.26%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.53.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 28.5, implying annual growth of -3.5%.
Current consensus DPS estimate is 20.9, implying a prospective dividend yield of 4.0%.
Current consensus EPS estimate suggests the PER is 18.4.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 23.00 cents and EPS of 31.30 cents.
At the last closing share price the estimated dividend yield is 4.39%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.74.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 29.5, implying annual growth of 3.5%.
Current consensus DPS estimate is 21.5, implying a prospective dividend yield of 4.1%.
Current consensus EPS estimate suggests the PER is 17.8.

Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

ESK    ETHERSTACK PLC

Telecommunication – Overnight Price: $0.23

Wilsons rates ((ESK)) as Overweight (1) –

Etherstack posted 2023 results that were below Wilsons' forecasts. No major new contracts were awarded in the second half yet the company asserts there is a strong pipeline of opportunities across its customer base, particularly with regard to land mobile radio.

The broker expects this should build a base for recurring revenue and the key catalyst is material contract wins.

The broker is positive about the stock although sensitive to the uncertainty surrounding closing large contracts in a timely manner. Overweight retained. Target is reduced to $0.40 from $0.58.

This report was published on February 26, 2024.

Target price is $0.40 Current Price is $0.23 Difference: $0.17
If ESK meets the Wilsons target it will return approximately 74% (excluding dividends, fees and charges).
The company's fiscal year ends in December.

Forecast for FY24:

Wilsons forecasts a full year FY24 dividend of 0.00 cents and EPS of 0.80 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 28.75.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of 1.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.43.

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

FMG    FORTESCUE LIMITED

Iron Ore – Overnight Price: $25.75

Goldman Sachs rates ((FMG)) as Sell (5) –

First half results from Fortescue were largely in line. Goldman Sachs notes there was no incremental news on the hydrogen projects and no update on the engineering studies and offtakes for the Phoenix project.

Operating guidance for FY24 is unchanged although management has indicated there is some work to be done in order to hit the lower end of the iron ore shipments guidance, given the derailment in late December. Sell rating retained. Target is $19.60.

This report was published on February 23, 2024.

Target price is $19.60 Current Price is $25.75 Difference: minus $6.15 (current price is over target).
If FMG meets the Goldman Sachs target it will return approximately minus 24% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $21.27, suggesting downside of -17.4%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Goldman Sachs forecasts a full year FY24 dividend of 200.52 cents and EPS of 311.41 cents.
At the last closing share price the estimated dividend yield is 7.79%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.27.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 321.7, implying annual growth of N/A.
Current consensus DPS estimate is 189.7, implying a prospective dividend yield of 7.4%.
Current consensus EPS estimate suggests the PER is 8.0.

Forecast for FY25:

Goldman Sachs forecasts a full year FY25 dividend of 92.66 cents and EPS of 174.69 cents.
At the last closing share price the estimated dividend yield is 3.60%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.74.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 244.9, implying annual growth of -23.9%.
Current consensus DPS estimate is 167.0, implying a prospective dividend yield of 6.5%.
Current consensus EPS estimate suggests the PER is 10.5.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: -0.9
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

GMG    GOODMAN GROUP

Infra & Property Developers – Overnight Price: $31.08

Jarden rates ((GMG)) as Overweight (2) –

Jarden believes the proposed internalisation of Goodman Property Trust (GMT.NZ) will set up both for stronger growth and returns from the New Zealand market.

For the parent it should remove the constraints of external management and, assuming attractive growth opportunities continue and external capital can be raised, provide much better returns. The broker expects financial impact will be neutral in the near term.

Goodman Group has performed strongly and continues to show a proactive approach to driving shareholder returns so Jarden believes its valuation premium is justified and retains an Overweight rating. Target is $30.50.

This report was published on February 26, 2024.

Target price is $30.50 Current Price is $31.08 Difference: minus $0.58 (current price is over target).
If GMG meets the Jarden target it will return approximately minus 2% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $29.11, suggesting downside of -6.3%(ex-dividends)

Forecast for FY24:

Current consensus EPS estimate is 106.3, implying annual growth of 28.0%.
Current consensus DPS estimate is 30.0, implying a prospective dividend yield of 1.0%.
Current consensus EPS estimate suggests the PER is 29.2.

Forecast for FY25:

Current consensus EPS estimate is 115.3, implying annual growth of 8.5%.
Current consensus DPS estimate is 31.1, implying a prospective dividend yield of 1.0%.
Current consensus EPS estimate suggests the PER is 27.0.

Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

GNX    GENEX POWER LIMITED

EV, Solar & Batteries – Overnight Price: $0.25

Petra Capital rates ((GNX)) as Buy (1) –

In a reminder to investors operating leverage works both ways, earnings (EBITDA) for Genex Power in the 1H fell by -$7.7m on the previous corresponding period after a -26.8% slide in sales revenue, explains Petra Capital.

The broker suggests investors focus on the longer-term value drivers, namely the de-risking and ultimate delivery of K2-Hydro, along with the development portfolio.

The Buy rating and 27.5c target were unchanged. Note: Petra Capital's research was penned prior to the $381m takeover bid for Genex Power from Japan's Electric Power Development.

This report was published on February 27, 2024.

Target price is $0.28 Current Price is $0.25 Difference: $0.025
If GNX meets the Petra Capital target it will return approximately 10% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Petra Capital forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 0.30 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 83.33.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of 0.00 cents.

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

GOR    GOLD ROAD RESOURCES LIMITED

Gold & Silver – Overnight Price: $1.62

Goldman Sachs rates ((GOR)) as Buy (1) –

Gold Road Resources reported underlying EBITDA for 2023 that was slightly below estimates. 2024 guidance is unchanged and the broker continues to believe this is conservative.

Goldman Sachs notes this is the only gold stock in its coverage without major expenditure on growth, which supports cash generation and near-term yields of 5-10% over 2024-27.

This is an attractive situation versus peers and supports upside to the outlook for capital returns, the broker adds. Buy rating retained. Target is $1.95.

This report was published on February 23, 2024.

Target price is $1.95 Current Price is $1.62 Difference: $0.325
If GOR meets the Goldman Sachs target it will return approximately 20% (excluding dividends, fees and charges).
Current consensus price target is $1.79, suggesting upside of 10.0%(ex-dividends)
The company's fiscal year ends in December.

Forecast for FY24:

Goldman Sachs forecasts a full year FY24 dividend of 3.00 cents and EPS of 10.00 cents.
At the last closing share price the estimated dividend yield is 1.85%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.25.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 9.3, implying annual growth of -13.3%.
Current consensus DPS estimate is 2.1, implying a prospective dividend yield of 1.3%.
Current consensus EPS estimate suggests the PER is 17.5.

Forecast for FY25:

Goldman Sachs forecasts a full year FY25 dividend of 2.00 cents and EPS of 11.00 cents.
At the last closing share price the estimated dividend yield is 1.23%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.77.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 11.8, implying annual growth of 26.9%.
Current consensus DPS estimate is 3.4, implying a prospective dividend yield of 2.1%.
Current consensus EPS estimate suggests the PER is 13.8.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

GTN    GTN LIMITED

Print, Radio & TV – Overnight Price: $0.48

Petra Capital rates ((GTN)) as Buy (1) –

Petra Capital assesses a robust 1H for GTN and suggests the business is well placed for FY24. Management didn't provide any commentary around 2H trading.

Brazil experienced a significant uptick for both revenue and profitability on increased utilisation, which the broker had already incorporated into forecasts.

The 68c target and Buy rating are maintained. Petra Capital expects continuing growth for GTN in international markets such as Brazil and Canada.

This report was published on February 27, 2024.

Target price is $0.68 Current Price is $0.48 Difference: $0.2
If GTN meets the Petra Capital target it will return approximately 42% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Petra Capital forecasts a full year FY24 dividend of 3.00 cents and EPS of 5.00 cents.
At the last closing share price the estimated dividend yield is 6.25%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.60.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 3.80 cents and EPS of 6.40 cents.
At the last closing share price the estimated dividend yield is 7.92%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.50.

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

IGO    IGO LIMITED

Nickel – Overnight Price: $7.62

Goldman Sachs rates ((IGO)) as Buy (1) –

An in line first half from IGO, according to Goldman Sachs, with the company announcing an 11 cents per share interim dividend alongside its largely pre-announced results.

A focus of the result was the net debt levels of the Greenbushes joint venture. Goldman Sachs estimates IGO's proportional debt at $0.1bn, but notes both IGO and the joint venture retain significant liquidity. 

The Buy rating is retained and the target price decreases to $8.00 from $8.85.

This report was published on February 23, 2024.

Target price is $8.00 Current Price is $7.62 Difference: $0.38
If IGO meets the Goldman Sachs target it will return approximately 5% (excluding dividends, fees and charges).
Current consensus price target is $7.89, suggesting upside of 3.5%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Goldman Sachs forecasts a full year FY24 dividend of 18.00 cents and EPS of 70.00 cents.
At the last closing share price the estimated dividend yield is 2.36%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.89.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 64.2, implying annual growth of -11.5%.
Current consensus DPS estimate is 12.6, implying a prospective dividend yield of 1.7%.
Current consensus EPS estimate suggests the PER is 11.9.

Forecast for FY25:

Goldman Sachs forecasts a full year FY25 dividend of 11.00 cents and EPS of 16.00 cents.
At the last closing share price the estimated dividend yield is 1.44%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 47.63.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 33.8, implying annual growth of -47.4%.
Current consensus DPS estimate is 11.8, implying a prospective dividend yield of 1.5%.
Current consensus EPS estimate suggests the PER is 22.5.

Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

IPH    IPH LIMITED

Legal – Overnight Price: $6.36

Jarden rates ((IPH)) as Overweight (2) –

Operating earnings in the first half were slightly weaker than expected from IPH yet Jarden remains attracted to the cash generation and capital-light business model. The long life of IP provides a high degree of revenue visibility and annuity-like earnings streams.

The broker also notes a significant number of pending patent applications over the next 2-5 years. Asian growth was soft yet management is confident in the long-term fundamentals. Overweight retained. Target rises to $10.10 from $9.65.

This report was published on February 23, 2024.

Target price is $10.10 Current Price is $6.36 Difference: $3.74
If IPH meets the Jarden target it will return approximately 59% (excluding dividends, fees and charges).
Current consensus price target is $8.91, suggesting upside of 40.1%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 32.30 cents and EPS of 43.00 cents.
At the last closing share price the estimated dividend yield is 5.08%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.79.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 45.4, implying annual growth of 58.6%.
Current consensus DPS estimate is 34.8, implying a prospective dividend yield of 5.5%.
Current consensus EPS estimate suggests the PER is 14.0.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 37.30 cents and EPS of 49.70 cents.
At the last closing share price the estimated dividend yield is 5.86%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.80.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 48.9, implying annual growth of 7.7%.
Current consensus DPS estimate is 37.2, implying a prospective dividend yield of 5.8%.
Current consensus EPS estimate suggests the PER is 13.0.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

JIN    JUMBO INTERACTIVE LIMITED

Gaming – Overnight Price: $17.19

Jarden rates ((JIN)) as Neutral (3) –

Jumbo Interactive posted first half results that exceeded expectations, with strong operating cost management and cash conversion. The final fully franked dividend of $0.27 represented an 82% payout, at the high-end of the guided range.

Jarden was pleased to see an expected recovery in jackpots towards the end of the first half, and a strong start to 2024 which has resulted in increased marketing expenditure to capture more incremental share. Neutral. Target is raised to $14.70 from $13.80.

This report was published on February 24, 2024.

Target price is $14.70 Current Price is $17.19 Difference: minus $2.49 (current price is over target).
If JIN meets the Jarden target it will return approximately minus 14% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $17.44, suggesting upside of 1.4%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 54.00 cents and EPS of 65.80 cents.
At the last closing share price the estimated dividend yield is 3.14%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 26.12.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 70.3, implying annual growth of 40.1%.
Current consensus DPS estimate is 56.1, implying a prospective dividend yield of 3.3%.
Current consensus EPS estimate suggests the PER is 24.5.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 50.00 cents and EPS of 73.80 cents.
At the last closing share price the estimated dividend yield is 2.91%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 23.29.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 78.9, implying annual growth of 12.2%.
Current consensus DPS estimate is 62.7, implying a prospective dividend yield of 3.6%.
Current consensus EPS estimate suggests the PER is 21.8.

Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

LAU    LINDSAY AUSTRALIA LIMITED

Transportation & Logistics – Overnight Price: $1.06

Wilsons rates ((LAU)) as Overweight (1) –

Lindsay Australia posted a mixed and overall weaker-than-expected first half. Transport beat Wilsons estimates while rural was behind as it was affected by adverse east coast weather and pressure on commodity prices.

Operating earnings (EBITDA) guidance has been revised to the lower end of the prior $102-108m range. The broker assesses the 12x PE multiple is undemanding and the growth assumptions underlying its assessment are conservative.

Catalysts for the share price may be delayed until FY25 with FY24 suspected to be a consolidation year. Overweight retained. Target is lifted to $1.76 from $1.70.

This report was published on February 27, 2024.

Target price is $1.76 Current Price is $1.06 Difference: $0.7
If LAU meets the Wilsons target it will return approximately 66% (excluding dividends, fees and charges).
Current consensus price target is $1.49, suggesting upside of 40.6%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Wilsons forecasts a full year FY24 dividend of 4.80 cents and EPS of 12.10 cents.
At the last closing share price the estimated dividend yield is 4.53%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.76.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 12.4, implying annual growth of 8.8%.
Current consensus DPS estimate is 5.0, implying a prospective dividend yield of 4.7%.
Current consensus EPS estimate suggests the PER is 8.5.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 5.80 cents and EPS of 14.60 cents.
At the last closing share price the estimated dividend yield is 5.47%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.26.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 13.6, implying annual growth of 9.7%.
Current consensus DPS estimate is 5.7, implying a prospective dividend yield of 5.4%.
Current consensus EPS estimate suggests the PER is 7.8.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

LFG    LIBERTY FINANCIAL GROUP LIMITED

Diversified Financials – Overnight Price: $4.19

Jarden rates ((LFG)) as Neutral (3) –

First half results from Liberty Financial revealed broadly stable margins and new mortgage volumes recovering from a low base, comment analysts at Jarden.

Jarden found the net interest margin in the half-year better than previously estimated and expects further improvements in flows, although elevated loan run-offs and higher bad debts should weigh on the pace of recovery.

The stock is considered an attractive proven cyclical business but positive earnings growth is not expected until FY25. Neutral retained. Target rises to $4.20 from $4.13.

This report was published on February 27, 2024.

Target price is $4.20 Current Price is $4.19 Difference: $0.01
If LFG meets the Jarden target it will return approximately 0% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 29.00 cents and EPS of 45.00 cents.
At the last closing share price the estimated dividend yield is 6.92%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.31.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 31.00 cents and EPS of 52.00 cents.
At the last closing share price the estimated dividend yield is 7.40%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.06.

Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

LOV    LOVISA HOLDINGS LIMITED

Retailing – Overnight Price: $30.55

Jarden rates ((LOV)) as Buy (1) –

Lovisa Holdings should start to cycle increasingly easier comparables. Jarden found the first half results robust and trading update particularly strong, given it was achieved despite a slowdown in the roll-out.

The broker retains a Buy rating, noting the business has multiple levers along with tailwinds to continue growing at a rate in keeping with its multiple. The gross profit margin expanded 47 basis points, and augurs well.  Target is raised to $28.69 from $23.79.

This report was published on February 23, 2024.

Target price is $28.69 Current Price is $30.55 Difference: minus $1.86 (current price is over target).
If LOV meets the Jarden target it will return approximately minus 6% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $29.27, suggesting downside of -4.2%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 61.00 cents and EPS of 73.70 cents.
At the last closing share price the estimated dividend yield is 2.00%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 41.45.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 78.3, implying annual growth of 23.8%.
Current consensus DPS estimate is 74.4, implying a prospective dividend yield of 2.4%.
Current consensus EPS estimate suggests the PER is 39.0.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 75.00 cents and EPS of 93.30 cents.
At the last closing share price the estimated dividend yield is 2.45%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 32.74.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 99.1, implying annual growth of 26.6%.
Current consensus DPS estimate is 86.4, implying a prospective dividend yield of 2.8%.
Current consensus EPS estimate suggests the PER is 30.8.

Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

MHJ    MICHAEL HILL INTERNATIONAL LIMITED

Luxury – Overnight Price: $0.68

Jarden rates ((MHJ)) as Overweight (2) –

Jarden notes the first half was challenging for Michael Hill with declining sales and contracting margins. Adjusting for acquisitions, the broker estimates underlying brand sales fell -10% with New Zealand and Australia particularly weak.

Going forward the consumer backdrop is expected to remain tough, particularly in New Zealand, where the business has historically had a higher incidence of products sold on credit.

Despite the difficult environment, Jarden retains an Overweight rating on a sector-relative basis, recognising management's track record and the fact the business is well-positioned to benefit from a turn in the consumer cycle. Target is lowered to NZ$1.05 from NZ$1.10.

This report was published on February 26, 2024.

Current Price is $0.68. Target price not assessed.
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 3.50 cents and EPS of 5.00 cents.
At the last closing share price the estimated dividend yield is 5.15%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.60.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 5.50 cents and EPS of 7.50 cents.
At the last closing share price the estimated dividend yield is 8.09%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.07.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

MYX    MAYNE PHARMA GROUP LIMITED

Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $7.24

Wilsons rates ((MYX)) as Upgrade to Overweight from Market Weight (1) –

Wilsons is finally satisfied that changes in accounting policies, data tracking and market approach by the new management team at Mayne Pharma are becoming sticky and the first half results have revealed tangible evidence of their efforts.

The positive view on the stock is being driven by Nextstellis, which for the first time since launch beat forecasts. This is a catalyst to upgrade to Overweight from Market Weight.

The broker assesses the material turnaround of the business is only getting started and it is time to buy. Target is raised to $7.38 from $5.50.

This report was published on February 27, 2024.

Target price is $7.38 Current Price is $7.24 Difference: $0.14
If MYX meets the Wilsons target it will return approximately 2% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Wilsons forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 42.80 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 16.92.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 3.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 206.86.

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

NAN    NANOSONICS LIMITED

Medical Equipment & Devices – Overnight Price: $2.73

Wilsons rates ((NAN)) as Upgrade to Overweight from Market Weight (1) –

Wilsons upgrades to Overweight from Market Weight despite reducing the Nanosonics EBIT estimates by -45% for FY25-26 as, with major Coris applications imminent and the fundamentals solid, its faith is unshaken.

The broker assesses the stock was sold off because the company announced concessions to enhance both the installed base additions and upgrade sales.

Wilsons believes the move was a long overdue stimulus for consumables and services earnings. Target is reduced to $3.45 from $3.95.

This report was published on February 27, 2024.

Target price is $3.45 Current Price is $2.73 Difference: $0.72
If NAN meets the Wilsons target it will return approximately 26% (excluding dividends, fees and charges).
Current consensus price target is $3.30, suggesting upside of 20.9%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Wilsons forecasts a full year FY24 dividend of 0.00 cents and EPS of 3.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 85.31.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 2.5, implying annual growth of -62.1%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 109.2.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of 2.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 105.00.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 5.3, implying annual growth of 112.0%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 51.5.

Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

NHF    NIB HOLDINGS LIMITED

Insurance – Overnight Price: $7.92

Jarden rates ((NHF)) as Neutral (3) –

The first half results from nib Holdings beat Jarden's estimates, largely reflecting provision releases which boosted earnings across the Australian resident health insurance division.

Underlying net margins were also stronger than expected, although the broker suspects the scope for upside is diminishing with regulatory scrutiny of premium rate increases and moderating policy growth.

With limited value headroom, Jarden retains a Neutral rating. Target is reduced to $7.75 from $7.95.

This report was published on February 27, 2024.

Target price is $7.75 Current Price is $7.92 Difference: minus $0.17 (current price is over target).
If NHF meets the Jarden target it will return approximately minus 2% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $8.07, suggesting upside of 1.9%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 30.00 cents and EPS of 42.00 cents.
At the last closing share price the estimated dividend yield is 3.79%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.86.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 46.5, implying annual growth of 12.3%.
Current consensus DPS estimate is 31.4, implying a prospective dividend yield of 4.0%.
Current consensus EPS estimate suggests the PER is 17.0.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 30.00 cents and EPS of 44.50 cents.
At the last closing share price the estimated dividend yield is 3.79%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.80.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 48.4, implying annual growth of 4.1%.
Current consensus DPS estimate is 32.1, implying a prospective dividend yield of 4.1%.
Current consensus EPS estimate suggests the PER is 16.4.

Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

NXD    NEXTED GROUP LIMITED

Education & Tuition – Overnight Price: $0.36

Petra Capital rates ((NXD)) as Buy (1) –

Petra Capital notes operating cash flow (OCF) was weak in the 1H for NextEd Group and management noted visa limitations are likely to significantly affect student enrolments.

The company withdrew 2H guidance due to heightened macroeconomic uncertainty resulting from this increased government scrutiny of international students entering Australia.

While the broker's Buy rating is unchanged, the broker's target is slashed to 55c from $1.00 on assumed weakness for the 2H.

This report was published on February 27, 2024.

Target price is $0.55 Current Price is $0.36 Difference: $0.19
If NXD meets the Petra Capital target it will return approximately 53% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Petra Capital forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 0.70 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 51.43.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of 0.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 60.00.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

OCL    OBJECTIVE CORPORATION LIMITED

IT & Support – Overnight Price: $13.34

Goldman Sachs rates ((OCL)) as Neutral (3) –

Goldman Sachs highlights the "solid" first half result from Objective Corp, with EBITDA ahead of estimates amid better gross margins on lower operating expenditure.

The broker notes the strong cost control and hails the fact the company allowed low-margin/non-core deals to churn yet envisages limited scope for the business to outperform in the absence of additional material deals. Neutral retained. Target is reduced to $13.75 from $13.80.

This report was published on February 23, 2024.

Target price is $13.75 Current Price is $13.34 Difference: $0.41
If OCL meets the Goldman Sachs target it will return approximately 3% (excluding dividends, fees and charges).
Current consensus price target is $12.00, suggesting downside of -10.0%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Goldman Sachs forecasts a full year FY24 dividend of 14.00 cents and EPS of 34.00 cents.
At the last closing share price the estimated dividend yield is 1.05%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 39.24.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 29.8, implying annual growth of 34.2%.
Current consensus DPS estimate is 14.7, implying a prospective dividend yield of 1.1%.
Current consensus EPS estimate suggests the PER is 44.8.

Forecast for FY25:

Goldman Sachs forecasts a full year FY25 dividend of 17.00 cents and EPS of 36.00 cents.
At the last closing share price the estimated dividend yield is 1.27%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 37.06.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 32.2, implying annual growth of 8.1%.
Current consensus DPS estimate is 16.5, implying a prospective dividend yield of 1.2%.
Current consensus EPS estimate suggests the PER is 41.4.

Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

PBH    POINTSBET HOLDINGS LIMITED

Gaming – Overnight Price: $0.81

Jarden rates ((PBH)) as Overweight (2) –

PointsBet has confirmed FY24 guidance of an EBITDA loss of -$9-14m. Jarden calculates the company is now tracking at break even or slightly profitable.

New information was limited in the report but the broker believes investors should be encouraged by the trajectory.

Separately, the appointment of Daniel Lucas as group chief technology officer has impressed the broker because of his experience and because it highlights the company's commitment to technology. Overweight retained. Target rises to $1.05 from $1.00.

This report was published on February 26, 2024.

Target price is $1.05 Current Price is $0.81 Difference: $0.235
If PBH meets the Jarden target it will return approximately 29% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 8.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 9.59.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 0.00 cents and EPS of 5.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.67.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

PLS    PILBARA MINERALS LIMITED

New Battery Elements – Overnight Price: $4.09

Jarden rates ((PLS)) as Buy (1) –

Jarden highlights the divergent strategies Australian lithium producers are devising in response to the weak commodity price and is reassured by the consistently rational approach from Pilbara Minerals, to maintain production growth and complete the expansion projects already underway.

The first half underlying EBITDA was in line with estimates and the broker highlights the benefits the company offers via its full ownership of a tier-1 operation. Buy retained. Target edges down to $4.14 from $4.30.

This report was published on February 23, 2024.

Target price is $4.14 Current Price is $4.09 Difference: $0.05
If PLS meets the Jarden target it will return approximately 1% (excluding dividends, fees and charges).
Current consensus price target is $3.59, suggesting downside of -12.2%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 0.00 cents and EPS of 12.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 32.46.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 11.8, implying annual growth of -85.2%.
Current consensus DPS estimate is 0.5, implying a prospective dividend yield of 0.1%.
Current consensus EPS estimate suggests the PER is 34.7.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 5.00 cents and EPS of 16.80 cents.
At the last closing share price the estimated dividend yield is 1.22%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 24.35.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 14.6, implying annual growth of 23.7%.
Current consensus DPS estimate is 3.7, implying a prospective dividend yield of 0.9%.
Current consensus EPS estimate suggests the PER is 28.0.

Market Sentiment: -0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

PNV    POLYNOVO LIMITED

Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $2.25

Wilsons rates ((PNV)) as Upgrade to Overweight from Market Weight (1) –

Wilsons upgrades its rating for PolyNovo to Overweight from Market Weight and raises its target to $2.44 from $1.79 following a 19% revenue beat in the 1H.

The broker feels the company's position within the US surgeon base has been solidified, particularly for large, difficult to treat burns.

In a rare feat relative to med-tech peers, note the analysts, PolyNovo's expansion outside of the US has progressed to the extent 25% of revenue is now derived from rest-of-the-world (ROW) markets. At the same time, gross margins have held at 95%.

This report was published on February 28, 2024.

Target price is $2.44 Current Price is $2.25 Difference: $0.19
If PNV meets the Wilsons target it will return approximately 8% (excluding dividends, fees and charges).
Current consensus price target is $2.01, suggesting downside of -10.9%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Wilsons forecasts a full year FY24 dividend of 0.00 cents and EPS of 0.70 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 321.43.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 0.7, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 321.4.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of 2.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 112.50.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 2.0, implying annual growth of 185.7%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 112.5.

Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

PPE    PEOPLEIN LIMITED

Jobs & Skilled Labour Services – Overnight Price: $1.03

Petra Capital rates ((PPE)) as Buy (1) –

While PeopleIN's underlying 1H earnings (EBITDA) of $20.2m were nearly half Petra Capital's $40.6m forecast for FY24, materially negative operating cash flow (OCF) drove a corresponding increase in gearing.

The analyst's net debt to earnings forecast for June 30 this year is 2.0 times compared to 1.5 times previously, which is at the top end of Petra Capital's comfort range, but still well below the company's debt covenants.

Reflecting changes in business mix to lower margin work across all divisions, the earnings margin fell by -210bps to 3.3%. Higher margin private sector work declined in Health & Community, while permanent recruitment in Professional Services also weakened.

The broker anticipates improved 2H cash flows and relatively stable earnings. The Buy rating is maintained and the target falls to $1.80 from $1.90.

This report was published on February 27, 2024.

Target price is $1.80 Current Price is $1.03 Difference: $0.77
If PPE meets the Petra Capital target it will return approximately 75% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Petra Capital forecasts a full year FY24 dividend of 6.50 cents and EPS of 21.20 cents.
At the last closing share price the estimated dividend yield is 6.31%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 4.86.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 9.00 cents and EPS of 21.60 cents.
At the last closing share price the estimated dividend yield is 8.74%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 4.77.

Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Wilsons rates ((PPE)) as Market Weight (3) –

PeopleIN delivered operating earnings (EBITDA) in the first half that were in line with Wilsons, despite being down -38% on the prior corresponding period.

Record revenue was achieved in industrial & specialist yet operating earnings were down -45%, and the broker notes the drop in business confidence affected the higher margin parts of the segment.

The broker notes the two recent acquisitions, FIP and Perigon, appear to be among the best performing businesses. No guidance was provided. Market Weight rating retained. Target is reduced to $1.16 from $1.39.

This report was published on February 27, 2024.

Target price is $1.16 Current Price is $1.03 Difference: $0.13
If PPE meets the Wilsons target it will return approximately 13% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Wilsons forecasts a full year FY24 dividend of 5.50 cents and EPS of 13.10 cents.
At the last closing share price the estimated dividend yield is 5.34%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.86.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 7.20 cents and EPS of 16.50 cents.
At the last closing share price the estimated dividend yield is 6.99%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 6.24.

Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

PPS    PRAEMIUM LIMITED

Wealth Management & Investments – Overnight Price: $0.39

Wilsons rates ((PPS)) as Upgrade to Overweight from Market Weight (1) –

First half results from Praemium slightly beat estimates. Wilsons was pleased with the result, having been initially sceptical of whether the company should participate in the OneVue sale process.

The coming year is expected to produce a rebound in trading volumes and improving market sentiment. The broker remains cognisant of adviser churn at key client, Escala, but believes this is factored in.

Rating is upgraded to Overweight from Market Weight and the target is lifted to $0.54 from $0.40.

This report was published on February 27, 2024.

Target price is $0.54 Current Price is $0.39 Difference: $0.155
If PPS meets the Wilsons target it will return approximately 40% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Wilsons forecasts a full year FY24 dividend of 0.00 cents and EPS of 2.10 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.33.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of 3.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.00.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

PSQ    PACIFIC SMILES GROUP LIMITED

Healthcare services – Overnight Price: $1.49

Wilsons rates ((PSQ)) as Upgrade to Market Weight from Underweight (3) –

Wilsons upgrades its rating for Pacific Smiles to Market Weight from Underweight having set a target of $1.40, up from 88c, to align with the indicative offer for the company by Genesis Capital.

The broker suggests investors resist and demand a higher price given 1H results demonstrated consistent growth, belying the recent discount applied by the analyst. It's felt the ‘self-funded expansion’ business model has been proven by the result.

Genesis Capital is promising a broadening of focus beyond shopping centres, improving the service mix and even citing potential M&A.

This report was published on February 28, 2024.

Target price is $1.40 Current Price is $1.49 Difference: minus $0.085 (current price is over target).
If PSQ meets the Wilsons target it will return approximately minus 6% (excluding dividends, fees and charges – negative figures indicate an expected loss).
The company's fiscal year ends in June.

Forecast for FY24:

Wilsons forecasts a full year FY24 dividend of 4.30 cents and EPS of 4.30 cents.
At the last closing share price the estimated dividend yield is 2.90%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 34.53.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 4.70 cents and EPS of 4.60 cents.
At the last closing share price the estimated dividend yield is 3.16%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 32.28.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

PXA    PEXA GROUP LIMITED

Real Estate – Overnight Price: $12.56

Goldman Sachs rates ((PXA)) as Neutral (3) –

First half results from Pexa Group were ahead of Goldman Sachs estimates. First half exchange EBITDA margins of 55.4% are tracking ahead of guidance, given improved mix.

The broker continues to envisage the business growing earnings into the second half and FY25, driven by a property market turnaround, incremental share gains and productivity benefits.

The unchanged margin guidance is considered conservative and Goldman Sachs suspects this reflects concerns regarding the macro environment and costs. Neutral retained. Target is raised 2% to $13.10.

This report was published on February 23, 2024.

Target price is $13.10 Current Price is $12.56 Difference: $0.54
If PXA meets the Goldman Sachs target it will return approximately 4% (excluding dividends, fees and charges).
Current consensus price target is $14.58, suggesting upside of 16.1%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Goldman Sachs forecasts a full year FY24 dividend of 0.00 cents and EPS of 22.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 57.09.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 16.5, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 76.1.

Forecast for FY25:

Goldman Sachs forecasts a full year FY25 dividend of 0.00 cents and EPS of 39.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 32.21.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 32.5, implying annual growth of 97.0%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 38.6.

Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Jarden rates ((PXA)) as Neutral (3) –

Net profit in the first half from PEXA Group missed forecasts while EBITDA was ahead. Jarden envisages potential for margins to sustain current levels as the domestic operating environment improves and further productivity gains are made.

While near-term earnings will drag, improved visibility on the UK is some way off and with limited value appeal the broker retains a Neutral rating. Target is raised to $11.65 from $11.50.

This report was published on February 23, 2024.

Target price is $11.65 Current Price is $12.56 Difference: minus $0.91 (current price is over target).
If PXA meets the Jarden target it will return approximately minus 7% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $14.58, suggesting upside of 16.1%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 0.00 cents and EPS of 12.10 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 103.80.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 16.5, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 76.1.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 0.00 cents and EPS of 39.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 32.21.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 32.5, implying annual growth of 97.0%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 38.6.

Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

QAN    QANTAS AIRWAYS LIMITED

Transportation & Logistics – Overnight Price: $5.01

Jarden rates ((QAN)) as Buy (1) –

Jarden observes the "solid" first half pre-tax profit from Qantas Airways was overshadowed by commentary regarding an earnings split returning to "normal" in FY24.

While this likely suggests meaningful pre-buyback EPS downgrades by consensus, it hides the fact the business is performing well and should enjoy cost mitigation into the second half along with a relatively stable yield environment.

Explicit capital expenditure guidance for FY24 of -$3-3.2bn and FY25 of -$3.7-3.9bn should also help guide the market, the broker adds. Buy rating retained. Target rises to $7.00 from $6.90.

This report was published on February 23, 2024.

Target price is $7.00 Current Price is $5.01 Difference: $1.99
If QAN meets the Jarden target it will return approximately 40% (excluding dividends, fees and charges).
Current consensus price target is $6.69, suggesting upside of 33.6%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 0.00 cents and EPS of 89.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 5.62.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 92.4, implying annual growth of -3.8%.
Current consensus DPS estimate is 1.7, implying a prospective dividend yield of 0.3%.
Current consensus EPS estimate suggests the PER is 5.4.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 25.50 cents and EPS of 102.20 cents.
At the last closing share price the estimated dividend yield is 5.09%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 4.90.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 99.4, implying annual growth of 7.6%.
Current consensus DPS estimate is 19.9, implying a prospective dividend yield of 4.0%.
Current consensus EPS estimate suggests the PER is 5.0.

Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

RDY    READYTECH HOLDINGS LIMITED

Software & Services – Overnight Price: $3.22

Wilsons rates ((RDY)) as Overweight (1) –

Management at ReadyTech Holdings has lowered FY24 organic revenue growth guidance to a low-double digit range from “mid-teens” due to short-term procurement delays, explains Wilsons.

Revenue in the 1H missed forecasts by consensus and the broker by -3% and -5%, respectively, due to those procurement delays in Workforce Solutions and Government & Justice. Earnings (EBITDA) and profit (NPATA) were also negatively impacted.

Management maintained earnings margin guidance at 34-35%, implying to the analysts a 2H margin of 36-37%.

Wilsons maintains there is an attractive EPS outlook, at a discount to peers, and the valuation gap should close as cash earnings margin expansion and EPS growth accelerates in the coming periods.

Overweight rating retained. The target slips to $3.91 from $4.04.

This report was published on February 28, 2024.

Target price is $3.91 Current Price is $3.22 Difference: $0.69
If RDY meets the Wilsons target it will return approximately 21% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Wilsons forecasts a full year FY24 dividend of 0.00 cents and EPS of 14.30 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 22.52.

Forecast for FY25:

Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of 18.70 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.22.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

REG    REGIS HEALTHCARE LIMITED

Aged Care & Seniors – Overnight Price: $3.76

Jarden rates ((REG)) as Overweight (2) –

Regis Healthcare delivered an operating result in the first half that was ahead of Jarden''s estimates, with higher government revenue the main driver. Net profit was lower than expected but this was largely because of one-off acquisition costs.

The broker expects momentum to continue into the second half with spot occupancy increasing to 94.5%. Further improvement to 95.8% is expected by FY26. The staff shortages are improving. Overweight retained. Target is raised to $3.64 from $3.35.

This report was published on February 26, 2024.

Target price is $3.64 Current Price is $3.76 Difference: minus $0.12 (current price is over target).
If REG meets the Jarden target it will return approximately minus 3% (excluding dividends, fees and charges – negative figures indicate an expected loss).
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 8.30 cents and EPS of 11.20 cents.
At the last closing share price the estimated dividend yield is 2.21%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 33.57.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 4.00 cents and EPS of 14.90 cents.
At the last closing share price the estimated dividend yield is 1.06%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 25.23.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

SFR    SANDFIRE RESOURCES LIMITED

Copper – Overnight Price: $7.90

Goldman Sachs rates ((SFR)) as Neutral (3) –

Sandfire Resources posted first half net profit that was slightly below Goldman Sachs' estimates.

No changes were made to operating guidance for FY24 although the broker notes expansion of Motheo to 5.2mtpa appears to be ahead of schedule, based on mill throughput rates achieved in January.

A maiden resource for the A1 it at Motheo is expected with the March quarter result. The broker continues to believe the stock is fairly valued and retains a Neutral rating with a $7.20 target.

This report was published on February 23, 2024.

Target price is $7.20 Current Price is $7.90 Difference: minus $0.7 (current price is over target).
If SFR meets the Goldman Sachs target it will return approximately minus 9% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $7.44, suggesting downside of -5.8%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Goldman Sachs forecasts a full year FY24 dividend of 2.30 cents and EPS of minus 6.00 cents.
At the last closing share price the estimated dividend yield is 0.29%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 131.67.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -6.6, implying annual growth of N/A.
Current consensus DPS estimate is 1.5, implying a prospective dividend yield of 0.2%.
Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY25:

Goldman Sachs forecasts a full year FY25 dividend of 20.20 cents and EPS of 65.32 cents.
At the last closing share price the estimated dividend yield is 2.56%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.09.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 37.9, implying annual growth of N/A.
Current consensus DPS estimate is 7.6, implying a prospective dividend yield of 1.0%.
Current consensus EPS estimate suggests the PER is 20.8.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Jarden rates ((SFR)) as Overweight (2) –

Sandfire Resources reported an interim result that was in line with estimates and has retained FY24 guidance.

Jarden was pleased with the maturing capital structure, noting the company is finalising documentation for a US$200m corporate revolver facility, which will initially be used to draw down repayment of the US$88m Matsa facility A.

The broker observes Motheo continues to ramp up well with the expanded plant already exceeding nameplate. Overweight. Target is steady at $6.50.

This report was published on February 23, 2024.

Target price is $6.50 Current Price is $7.90 Difference: minus $1.4 (current price is over target).
If SFR meets the Jarden target it will return approximately minus 18% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $7.44, suggesting downside of -5.8%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 10.03 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 78.80.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -6.6, implying annual growth of N/A.
Current consensus DPS estimate is 1.5, implying a prospective dividend yield of 0.2%.
Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 7.60 cents and EPS of 51.34 cents.
At the last closing share price the estimated dividend yield is 0.96%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.39.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 37.9, implying annual growth of N/A.
Current consensus DPS estimate is 7.6, implying a prospective dividend yield of 1.0%.
Current consensus EPS estimate suggests the PER is 20.8.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

SMR    STANMORE RESOURCES LIMITED

Coal – Overnight Price: $3.41

Petra Capital rates ((SMR)) as Buy (1) –

Petra Capital assesses a "solid" FY23 result for Stanmore Resources even though earnings (EBITDA) fell -6% below the broker's forecast on lower coal prices and higher non-operating expenses.

Higher-than-expected financing costs and D&A expense also drove a material profit miss, explains the analyst. Cash flow was considered strong, allowing a balance between future commitments (capex and M&A-related payments), growth and dividends.

A final fully franked dividend of US8.4cps was declared, missing Petra Capital's forecast for US11.6cps.

The Buy rating is retained and the target price rises to $5.52 from $5.44.

This report was published on February 27, 2024.

Target price is $5.52 Current Price is $3.41 Difference: $2.11
If SMR meets the Petra Capital target it will return approximately 62% (excluding dividends, fees and charges).
The company's fiscal year ends in December.

Forecast for FY24:

Petra Capital forecasts a full year FY24 dividend of 23.24 cents and EPS of 74.43 cents.
At the last closing share price the estimated dividend yield is 6.82%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 4.58.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 16.20 cents and EPS of 49.40 cents.
At the last closing share price the estimated dividend yield is 4.75%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 6.90.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

STX    STRIKE ENERGY LIMITED

NatGas – Overnight Price: $0.21

Goldman Sachs rates ((STX)) as Buy (1) –

Strike Energy's South Erregulla-2 flow test has resulted in gas information water produced to surface albeit not yet resulting in a strong flow rates observed at other discoveries including SE-1, West Erregulla or Walyering.

This result follows a poor outcome at SE-3 which also failed to produce the expected gas rates during testing.

Given the results and lack of an update on domestic gas policy, Goldman Sachs removes the $0.11/share ascribed to South Erregulla 2C resources and lowers the target to $0.31 from $0.50.

Buy rating retained as current pricing implies no upside for future potential exploration or appraisal success.

This report was published on February 23, 2024.

Target price is $0.50 Current Price is $0.21 Difference: $0.285
If STX meets the Goldman Sachs target it will return approximately 133% (excluding dividends, fees and charges).
Current consensus price target is $0.28, suggesting upside of 28.7%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Goldman Sachs forecasts a full year FY24 dividend of 0.00 cents and EPS of 0.30 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 71.67.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 0.5, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 43.0.

Forecast for FY25:

Goldman Sachs forecasts a full year FY25 dividend of 0.00 cents and EPS of 0.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 35.83.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 1.4, implying annual growth of 180.0%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 15.4.

Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

SUN    SUNCORP GROUP LIMITED

Insurance – Overnight Price: $15.34

Jarden rates ((SUN)) as Downgrade to Overweight from Buy (2) –

Jarden observes the lower bank earnings cast a shadow over the first half result from Suncorp Group, but with the bank sale on track to be completed in early FY25, stronger general insurance earnings were a highlight.

Underlying ITR margins appear on track for the top end of the 10-12% target range in the second half, despite the company reducing its reliance on reserve releases and absorbing a higher catastrophe budget.

The broker believes the business is well-positioned to deliver, yet with more modest value appeal the rating is lowered to Overweight from Buy. Target is raised to $15.95 from $15.25.

This report was published on February 27, 2024.

Target price is $15.95 Current Price is $15.34 Difference: $0.61
If SUN meets the Jarden target it will return approximately 4% (excluding dividends, fees and charges).
Current consensus price target is $16.31, suggesting upside of 6.3%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 75.00 cents and EPS of 107.30 cents.
At the last closing share price the estimated dividend yield is 4.89%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.30.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 105.2, implying annual growth of 15.7%.
Current consensus DPS estimate is 73.6, implying a prospective dividend yield of 4.8%.
Current consensus EPS estimate suggests the PER is 14.6.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 121.00 cents and EPS of 104.70 cents.
At the last closing share price the estimated dividend yield is 7.89%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.65.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 107.9, implying annual growth of 2.6%.
Current consensus DPS estimate is 88.6, implying a prospective dividend yield of 5.8%.
Current consensus EPS estimate suggests the PER is 14.2.

Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

TAH    TABCORP HOLDINGS LIMITED

Gaming – Overnight Price: $0.79

Jarden rates ((TAH)) as Overweight (2) –

First half revenue reflected soft market conditions for Tabcorp Holdings and, while largely expected, Jarden notes it were fixed costs that led to significant deleveraging that disappointed the market.

Guidance has been maintained for expenditure in FY24 and FY25 and the broker notes an improvement in Queensland following the move to a level playing field.

The broker expects that as markets normalise the online operators, which will be paying more share of taxes, will become less profitable.  Overweight. Target is reduced to $0.95 from $1.15.

This report was published on February 23, 2024.

Target price is $0.95 Current Price is $0.79 Difference: $0.165
If TAH meets the Jarden target it will return approximately 21% (excluding dividends, fees and charges).
Current consensus price target is $0.94, suggesting upside of 19.7%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 1.90 cents and EPS of 2.20 cents.
At the last closing share price the estimated dividend yield is 2.42%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 35.68.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 2.8, implying annual growth of -4.4%.
Current consensus DPS estimate is 2.0, implying a prospective dividend yield of 2.5%.
Current consensus EPS estimate suggests the PER is 28.0.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 2.60 cents and EPS of 4.30 cents.
At the last closing share price the estimated dividend yield is 3.31%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.26.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 5.1, implying annual growth of 82.1%.
Current consensus DPS estimate is 3.0, implying a prospective dividend yield of 3.8%.
Current consensus EPS estimate suggests the PER is 15.4.

Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

TLX    TELIX PHARMACEUTICALS LIMITED

Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $11.74

Jarden rates ((TLX)) as Buy (1) –

The Telix Pharmaceuticals 2023 result was welcomed by Jarden now the company is cash flow positive and the focus is shifting further down the profit and loss statement.

Adjusted EBITDA missed forecasts because of an increase in R&D which steps up significantly in 2024.

The company is now in the "enviable position" to self fund numerous R&D projects so the broker suggests the increase should not be a big surprise, given the depth of the product pipeline. Buy rating retained. Target rises to $13.27 from $13.08.

This report was published on February 23, 2024.

Target price is $13.27 Current Price is $11.74 Difference: $1.53
If TLX meets the Jarden target it will return approximately 13% (excluding dividends, fees and charges).
The company's fiscal year ends in December.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 0.00 cents and EPS of 10.80 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 108.70.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 0.00 cents and EPS of 34.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 34.13.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

TPG    TPG TELECOM LIMITED

Telecommunication – Overnight Price: $4.63

Jarden rates ((TPG)) as Downgrade to Overweight from Buy (2) –

Gross profit at TPG Telecom was marginally ahead of Jarden's estimates in 2023 although fixed costs were materially worse than expected. Guidance for 2024 EBITDA of $1.95-2.025bn is below the broker's estimates.

While continuing to envisage potential for material earnings growth over the next three years as a result of improving industry returns and fundamental valuation support, the broker's conviction has softened. The rating is cut to Overweight from Buy and the target reduced to $5.30 from $5.80.

This report was published on February 27, 2024.

Target price is $5.30 Current Price is $4.63 Difference: $0.67
If TPG meets the Jarden target it will return approximately 14% (excluding dividends, fees and charges).
Current consensus price target is $5.31, suggesting upside of 14.7%(ex-dividends)
The company's fiscal year ends in December.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 18.00 cents and EPS of 13.90 cents.
At the last closing share price the estimated dividend yield is 3.89%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 33.31.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 16.0, implying annual growth of 506.1%.
Current consensus DPS estimate is 19.3, implying a prospective dividend yield of 4.2%.
Current consensus EPS estimate suggests the PER is 28.9.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 19.10 cents and EPS of 18.80 cents.
At the last closing share price the estimated dividend yield is 4.13%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 24.63.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 18.0, implying annual growth of 12.5%.
Current consensus DPS estimate is 18.3, implying a prospective dividend yield of 4.0%.
Current consensus EPS estimate suggests the PER is 25.7.

Market Sentiment: -0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

UNI    UNIVERSAL STORE HOLDINGS LIMITED

Apparel & Footwear – Overnight Price: $4.80

Jarden rates ((UNI)) as Overweight (2) –

Universal Store posted a strong first half with net profit beating estimates. Jarden also notes momentum has continued in the trading update for the first seven weeks of the second half.

As comparables will become significantly easier and there is a sustainable long-term roll-out, Jarden reiterates a Buy rating, highlighting significant upside to the target, raised to $5.20 from $5.04. EBIT forecasts are upgraded by 8% for FY24 and 3% for FY25.

This report was published on February 23, 2024.

Target price is $5.20 Current Price is $4.80 Difference: $0.4
If UNI meets the Jarden target it will return approximately 8% (excluding dividends, fees and charges).
Current consensus price target is $5.33, suggesting upside of 11.0%(ex-dividends)
The company's fiscal year ends in June.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 23.00 cents and EPS of 35.80 cents.
At the last closing share price the estimated dividend yield is 4.79%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.41.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 37.2, implying annual growth of 14.5%.
Current consensus DPS estimate is 25.8, implying a prospective dividend yield of 5.4%.
Current consensus EPS estimate suggests the PER is 12.9.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 26.00 cents and EPS of 41.90 cents.
At the last closing share price the estimated dividend yield is 5.42%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.46.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 42.6, implying annual growth of 14.5%.
Current consensus DPS estimate is 29.0, implying a prospective dividend yield of 6.0%.
Current consensus EPS estimate suggests the PER is 11.3.

Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

VIT    VITURA HEALTH LIMITED

Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $0.14

Petra Capital rates ((VIT)) as Buy (1) –

Petra Capital lowers its target for Vitura Health to 24c from 61c following lower-than-expected 1H average revenue per user (ARPU) which dropped to $110 from $130 in the previous corresponding period.

Management attributed the decline in ARPU to increased price competition in the medical cannabis industry and a halt in unit sales growth due to market saturation. Gross margins fell to 29.4% in the 1H from 35.2% in the 1H of FY23.

The analyst still sees growth from many new product lines, the most promising being smoking cessation, and the Buy rating is maintained.

This report was published on February 27, 2024.

Target price is $0.24 Current Price is $0.14 Difference: $0.095
If VIT meets the Petra Capital target it will return approximately 66% (excluding dividends, fees and charges).
The company's fiscal year ends in June.

Forecast for FY24:

Petra Capital forecasts a full year FY24 dividend of 1.00 cents and EPS of 1.40 cents.
At the last closing share price the estimated dividend yield is 6.90%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.36.

Forecast for FY25:

Petra Capital forecasts a full year FY25 dividend of 1.00 cents and EPS of 1.70 cents.
At the last closing share price the estimated dividend yield is 6.90%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.53.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

WDS    WOODSIDE ENERGY GROUP LIMITED

NatGas – Overnight Price: $30.52

Jarden rates ((WDS)) as Underweight (4) –

Woodside has announced the sale of a 15.1% stake in Scarborough LNG for $1.4bn to the Japanese utility, JERA. Jarden acknowledges the sale reduces the exposure of the company to the upstream portion of this 8mtpa project and its share of the construction cost.

The interest in Scarborough will reduce to 74.9% post completion. Underweight rating retained. Target slips to $28.75 from $29.00.

This report was published on February 23, 2024.

Target price is $28.75 Current Price is $30.52 Difference: minus $1.77 (current price is over target).
If WDS meets the Jarden target it will return approximately minus 6% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $33.70, suggesting upside of 10.4%(ex-dividends)
The company's fiscal year ends in December.

Forecast for FY24:

Jarden forecasts a full year FY24 dividend of 176.21 cents and EPS of 222.09 cents.
At the last closing share price the estimated dividend yield is 5.77%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.74.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 195.2, implying annual growth of N/A.
Current consensus DPS estimate is 152.6, implying a prospective dividend yield of 5.0%.
Current consensus EPS estimate suggests the PER is 15.6.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 186.85 cents and EPS of 234.24 cents.
At the last closing share price the estimated dividend yield is 6.12%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.03.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 168.3, implying annual growth of -13.8%.
Current consensus DPS estimate is 127.2, implying a prospective dividend yield of 4.2%.
Current consensus EPS estimate suggests the PER is 18.1.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

WPR    WAYPOINT REIT LIMITED

REITs – Overnight Price: $2.39

Moelis rates ((WPR)) as Buy (1) –

An in line FY23 result from Waypoint REIT according to Moelis, with the company reporting earnings and dividends of 16.48 cents per share.

The REIT is now guiding to distributable earnings of 16.32-16.48 cents per share for FY24. Moelis points out the top end of this range misses its previous estimates by -2%, accounting for a plan to refinance debt facilities this year.

It is expected the REIT will undertake the divestment of non-core assets totalling around -$80m over the years, which have been a strategic target for a number of years now. 

The Buy rating is retained and the target price decreases to $2.79 from $2.84.

This report was published on February 26, 2024.

Target price is $2.79 Current Price is $2.39 Difference: $0.4
If WPR meets the Moelis target it will return approximately 17% (excluding dividends, fees and charges).
Current consensus price target is $2.48, suggesting upside of 3.6%(ex-dividends)
The company's fiscal year ends in December.

Forecast for FY24:

Moelis forecasts a full year FY24 dividend of 16.50 cents and EPS of 16.50 cents.
At the last closing share price the estimated dividend yield is 6.90%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.48.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 16.2, implying annual growth of N/A.
Current consensus DPS estimate is 16.3, implying a prospective dividend yield of 6.8%.
Current consensus EPS estimate suggests the PER is 14.8.

Forecast for FY25:

Moelis forecasts a full year FY25 dividend of 16.40 cents and EPS of 16.40 cents.
At the last closing share price the estimated dividend yield is 6.86%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.57.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 16.9, implying annual growth of 4.3%.
Current consensus DPS estimate is 16.9, implying a prospective dividend yield of 7.1%.
Current consensus EPS estimate suggests the PER is 14.1.

Market Sentiment: -0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don't have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.

This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.

Decisions about inclusions in this Report are made independently of the providers of stock market research and at full discretion of the team of journalists responsible for content at FNArena. Inclusion does not equal endorsement, in any way, shape or form. This Report is provided for informational purposes only.

Share on FacebookTweet about this on TwitterShare on LinkedIn

Click to view our Glossary of Financial Terms

CHARTS

29M ABB ACE ADH ASB ASG AVA AX1 BXB CCR CMM CSR CYG EDV ESK FMG GMG GNX GOR GTN IGO IPH JIN LAU LFG LOV MHJ MYX NAN NHF NXD OCL PBH PLS PNV PPE PPS PSQ PXA QAN RDY REG SFR SLC SMR STX SUN TAH TLX TPG UNI VIT WDS WPR

For more info SHARE ANALYSIS: 29M - 29METALS LIMITED

For more info SHARE ANALYSIS: ABB - AUSSIE BROADBAND LIMITED

For more info SHARE ANALYSIS: ACE - ACUSENSUS LIMITED

For more info SHARE ANALYSIS: ADH - ADAIRS LIMITED

For more info SHARE ANALYSIS: ASB - AUSTAL LIMITED

For more info SHARE ANALYSIS: ASG - AUTOSPORTS GROUP LIMITED

For more info SHARE ANALYSIS: AVA - AVA RISK GROUP LIMITED

For more info SHARE ANALYSIS: AX1 - ACCENT GROUP LIMITED

For more info SHARE ANALYSIS: BXB - BRAMBLES LIMITED

For more info SHARE ANALYSIS: CCR - CREDIT CLEAR LIMITED

For more info SHARE ANALYSIS: CMM - CAPRICORN METALS LIMITED

For more info SHARE ANALYSIS: CSR - CSR LIMITED

For more info SHARE ANALYSIS: CYG - COVENTRY GROUP LIMITED

For more info SHARE ANALYSIS: EDV - ENDEAVOUR GROUP LIMITED

For more info SHARE ANALYSIS: ESK - ETHERSTACK PLC

For more info SHARE ANALYSIS: FMG - FORTESCUE LIMITED

For more info SHARE ANALYSIS: GMG - GOODMAN GROUP

For more info SHARE ANALYSIS: GNX - GENEX POWER LIMITED

For more info SHARE ANALYSIS: GOR - GOLD ROAD RESOURCES LIMITED

For more info SHARE ANALYSIS: GTN - GTN LIMITED

For more info SHARE ANALYSIS: IGO - IGO LIMITED

For more info SHARE ANALYSIS: IPH - IPH LIMITED

For more info SHARE ANALYSIS: JIN - JUMBO INTERACTIVE LIMITED

For more info SHARE ANALYSIS: LAU - LINDSAY AUSTRALIA LIMITED

For more info SHARE ANALYSIS: LFG - LIBERTY FINANCIAL GROUP LIMITED

For more info SHARE ANALYSIS: LOV - LOVISA HOLDINGS LIMITED

For more info SHARE ANALYSIS: MHJ - MICHAEL HILL INTERNATIONAL LIMITED

For more info SHARE ANALYSIS: MYX - MAYNE PHARMA GROUP LIMITED

For more info SHARE ANALYSIS: NAN - NANOSONICS LIMITED

For more info SHARE ANALYSIS: NHF - NIB HOLDINGS LIMITED

For more info SHARE ANALYSIS: NXD - NEXTED GROUP LIMITED

For more info SHARE ANALYSIS: OCL - OBJECTIVE CORPORATION LIMITED

For more info SHARE ANALYSIS: PBH - POINTSBET HOLDINGS LIMITED

For more info SHARE ANALYSIS: PLS - PILBARA MINERALS LIMITED

For more info SHARE ANALYSIS: PNV - POLYNOVO LIMITED

For more info SHARE ANALYSIS: PPE - PEOPLEIN LIMITED

For more info SHARE ANALYSIS: PPS - PRAEMIUM LIMITED

For more info SHARE ANALYSIS: PSQ - PACIFIC SMILES GROUP LIMITED

For more info SHARE ANALYSIS: PXA - PEXA GROUP LIMITED

For more info SHARE ANALYSIS: QAN - QANTAS AIRWAYS LIMITED

For more info SHARE ANALYSIS: RDY - READYTECH HOLDINGS LIMITED

For more info SHARE ANALYSIS: REG - REGIS HEALTHCARE LIMITED

For more info SHARE ANALYSIS: SFR - SANDFIRE RESOURCES LIMITED

For more info SHARE ANALYSIS: SLC - SUPERLOOP LIMITED

For more info SHARE ANALYSIS: SMR - STANMORE RESOURCES LIMITED

For more info SHARE ANALYSIS: STX - STRIKE ENERGY LIMITED

For more info SHARE ANALYSIS: SUN - SUNCORP GROUP LIMITED

For more info SHARE ANALYSIS: TAH - TABCORP HOLDINGS LIMITED

For more info SHARE ANALYSIS: TLX - TELIX PHARMACEUTICALS LIMITED

For more info SHARE ANALYSIS: TPG - TPG TELECOM LIMITED

For more info SHARE ANALYSIS: UNI - UNIVERSAL STORE HOLDINGS LIMITED

For more info SHARE ANALYSIS: VIT - VITURA HEALTH LIMITED

For more info SHARE ANALYSIS: WDS - WOODSIDE ENERGY GROUP LIMITED

For more info SHARE ANALYSIS: WPR - WAYPOINT REIT LIMITED